Company Search:
Advanced Search
Sponsored Links
Principia Biopharma Inc Company Snapshot
Principia Biopharma Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Principia Biopharma Inc with three other companies in this sector in the United States: Spark Therapeutics Inc (2018 sales of $64.73 million of which 100% was Healthcare Services), Jounce Therapeutics Inc ($65.20 million of which 100% was Immunotherapy), and Recro Pharma Inc ($77.35 million of which 100% was CDMO).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Principia Biopharma Inc
  Stock Performance Chart for Principia Biopharma Inc
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): 37.39
(Figures in U.S. Dollars)
1 Week 4.4%   13 Weeks 18.3%  
4 Weeks 0.0%   52 Weeks 23.6%  
Principia Biopharma Inc Key Data:
  Ticker: PRNB Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 69,137,000
(Year Ending Jan 2019).
Employees: 69
  Currency: U.S. Dollars Market Cap: 902,164,839
  Fiscal Yr Ends: December Shares Outstanding: 24,128,506
  Share Type: Common Closely Held Shares: 3,321,172
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.